journal article·2022-06Open access

Co-electrospun-electrosprayed PVA/folic acid nanofibers for transdermal drug delivery: Preparation, characterization, and in vitro cytocompatibility

Fatma Nur Parın, Çiğdem İnci Aydemir, Gökçe Taner, Kenan Yıldırım

Journal of Industrial Textiles· Volume 51· Issue 1_suppl

Abstract

In this study, hydrophilic based bioactive nanofibers were produced via an electrospinning and electrospraying simultaneous process. Poly(vinyl alcohol) (PVA), poly(vinyl alcohol)-gelatin (PVA-Gel), and poly(vinyl alcohol)-alginate (PVA-Alg) polymers were used as the matrix material and folic acid (FA) particles were dispersed simultaneously on the surface of the nanofibers. The morphology of the nanofibers (NFs) was uniform and confirmed by scanning electron microscopy. Thermal behavior, chemical structure of the composite nanofibers were investigated by thermogravimetric analysis, and Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy which showed that no chemical bonding between vitamin and polymers. A fast release of FA-loaded electrospun fibers was carried out by UV-Vis in vitro study within the 8 hour-period in artificial sweat solutions (pH 5.44). The obtained PVA/FA, PVA-Gel/FA, and PVA-Alg/FA fibers released 49.6%, 69.55%, and 50.88% of the sprayed FA in 8 h, indicating the influence of polymer matrix and polymer-drug interactions, on its release from the polymer matrix. Moreover, biocompatibility of all developed novel NFs was assessed by two different cytotoxicity tests, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and neutral red uptake (NRU) assay in L929 (mouse fibroblasts) cell lines. In all cases, it is concluded that these new electrospun fibers had fast-release of the vitamin and the hybrid process is suitable for transdermal patch applications, especially for skin-care products. The results of cytocompatibility assays on L929 reveal that all prepared NFs have no or slight cell toxicity. PVA and PVA-Gel with/without FA nanofibers seems more biocompatible than PVA-Alg nanofibers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Advanced Sensor and Energy Harvesting Materials · Electrohydrodynamics and Fluid Dynamics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Polymer Materials Engineering, Faculty of Engineering and Natural Sciences, Bursa Technical University, Bursa, Turkey

Biotechnology Program, Graduate School of Natural and Applied Sciences, Bursa Technical University, Bursa, Turkey

Department of Bioengineering, Faculty of Engineering and Natural Sciences, Bursa Technical University, Bursa, Turkey

Central Research Laboratory, Bursa Technical University, Bursa, Turkey

Funding

Bursa Technical University

References (79)

Show source-provided references
1. 10.1016/j.jddst.2017.07.00310.1016/j.jddst.2017.07.003 ↗
2. Geerligs M. Skin layer mechanism. Eindhoven, The Netherlands: Eindhover University of Technology, 2009, pp.4–5.
3. Rodrigues F, Cádiz-Gurrea ML, Nunes MA, et al. Chapter 12: Cosmetics. In: Charis G (Ed.) Polyphenols: properties, recovery, and applications . Vienna, Austria: Elsevier, 2018, pp.393–427.10.1016/B978-0-12-813572-3.00012-9 ↗
4. 10.1208/s12249-019-1362-710.1208/s12249-019-1362-7 ↗
5. Mancini AJ, Krowchuk DP. Pediatric dermatology. 3rd ed. Itasca, IL: American Academy of Pediatrics, 2016, pp.1–2.10.1542/9781610020213 ↗
6. Parikh SA, Kelsey A, Finch J, et al. Chapter 10: Skin health and healthy aging: skin cosmetics. In: Patrick PC (Ed.) Healthy aging. Switzerland: Springer Nature, 2019, pp.105–113.10.1007/978-3-030-06200-2_10 ↗
7. 10.1002/j.1552-4604.1991.tb01895.x10.1002/j.1552-4604.1991.tb01895.x ↗
8. 10.1016/j.jconrel.2015.10.04910.1016/j.jconrel.2015.10.049 ↗
9. Banga AK. · Drug Dev Ind Pharm · 2011 · 38 · 513
10. Murthy SN. · Res and Rep Trans Drug Deliv · 2012 · 1 · 1
11. 10.1590/s2175-9790201800000100810.1590/s2175-97902018000001008 ↗
12. 10.1034/j.1600-0625.2000.009003165.x10.1034/j.1600-0625.2000.009003165.x ↗
13. 10.1021/acs.cgd.6b0004310.1021/acs.cgd.6b00043 ↗
14. 10.17265/2159-5313/2016.09.00310.17265/2159-5313/2016.09.003 ↗
15. 10.1208/s12249-009-9363-610.1208/s12249-009-9363-6 ↗
16. 10.1155/2009/97968010.1155/2009/979680 ↗
17. 10.4028/www.scientific.net/AMR.549.7410.4028/www.scientific.net/AMR.549.74 ↗
18. 10.1016/j.powtec.2015.11.01910.1016/j.powtec.2015.11.019 ↗
19. 10.1016/j.freeradbiomed.2013.08.16810.1016/j.freeradbiomed.2013.08.168 ↗
20. 10.1080/00405000.2020.177319910.1080/00405000.2020.1773199 ↗
21. 10.35530/IT.069.01.150210.35530/IT.069.01.1502 ↗
22. 10.1016/j.ijpharm.2014.04.04710.1016/j.ijpharm.2014.04.047 ↗
23. Arthanari S · Artif Cell Nanomed B · 2016 · 44 · 847
24. 10.1080/10667857.2019.164988810.1080/10667857.2019.1649888 ↗
25. Esentürk · J Fac Pharm · 2016 · 46 · 49
26. 10.1098/rsos.20126610.1098/rsos.201266 ↗
27. 10.3109/21691401.2016.117304710.3109/21691401.2016.1173047 ↗
28. 10.1080/10837450.2019.170656310.1080/10837450.2019.1706563 ↗
29. 10.1016/j.colsurfa.2019.12426710.1016/j.colsurfa.2019.124267 ↗
30. 10.1016/j.jddst.2020.10204410.1016/j.jddst.2020.102044 ↗
31. 10.1186/s40580-015-0047-510.1186/s40580-015-0047-5 ↗
32. 10.1016/j.ijpharm.2013.01.04010.1016/j.ijpharm.2013.01.040 ↗
33. 10.1088/2053-1591/ab8fea10.1088/2053-1591/ab8fea ↗
34. 10.3390/polym1207148810.3390/polym12071488 ↗
35. 10.35530/IT.071.02.179310.35530/IT.071.02.1793 ↗
36. He L, Zhao Y, Tian L, et al. Electrospraying and electrospinning for nanobiomaterial fabrication nanobiomaterials: classification, fabrication and biomedical applications . 1st ed. Piscataway, NJ: Wiley, Chapter 6, 2018, pp.143–163.10.1002/9783527698646.ch6 ↗
37. 10.4161/biom.2428110.4161/biom.24281 ↗
38. 10.1088/1468-6996/12/5/05500410.1088/1468-6996/12/5/055004 ↗
39. Schmid-Wendtner MH · Pharmacol Physiol · 2006 · 19 · 296
40. 10.1016/j.ejps.2016.08.04510.1016/j.ejps.2016.08.045 ↗
41. International Organization for Standardization, ISO 105-E04:2013. Textiles-tests for colourfastness – part E04: colourfastness to perspiration . Geneva, Switzerland: International Organization for Standardization.
42. International Organization for Standardization, UNI EN ISO 10993-5:2009. Biological evaluation of medical devices - part 5: in vitro cytotoxicity testing . Geneva, Switzerland: International Organization for Standardization.
43. 10.1177/02611929050330031310.1177/026119290503300313 ↗
44. International Organization for Standardization, UNI EN ISO 10993-12:2009. Biological evaluation of medical devices - part 12: preparation of samples and reference materials . Geneva, Switzerland: International Organization for Standardization.
45. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
46. 10.1016/0022-1759(89)90397-910.1016/0022-1759(89)90397-9 ↗
47. 10.1016/j.fitote.2012.03.00610.1016/j.fitote.2012.03.006 ↗
48. 10.1016/j.toxlet.2004.04.00510.1016/j.toxlet.2004.04.005 ↗
49. 10.1016/j.tiv.2011.12.01110.1016/j.tiv.2011.12.011 ↗
50. Medeiros ES · J Biobased Mater · 2008 · 2 · 110.1166/jbmb.2008.204 ↗
51. 10.1177/004051751247174610.1177/0040517512471746 ↗
52. 10.1021/la502310410.1021/la5023104 ↗
53. 10.1088/1748-605X/ab673b10.1088/1748-605X/ab673b ↗
54. 10.1155/2013/78928910.1155/2013/789289 ↗
55. 10.1016/j.heliyon.2018.e0059210.1016/j.heliyon.2018.e00592 ↗
56. 10.1002/pi.290510.1002/pi.2905 ↗
57. 10.1088/0957-4484/17/9/04110.1088/0957-4484/17/9/041 ↗
58. 10.6000/1929-5995.2019.08.0210.6000/1929-5995.2019.08.02 ↗
59. 10.1016/j.colsurfa.2010.05.03810.1016/j.colsurfa.2010.05.038 ↗
60. 10.1155/2014/52568410.1155/2014/525684 ↗
61. 10.7897/2230-8407.09918010.7897/2230-8407.099180 ↗
62. 10.1007/s10967-020-07058-z10.1007/s10967-020-07058-z ↗
63. 10.1515/phys-2017-012510.1515/phys-2017-0125 ↗
64. 10.1016/j.chemosphere.2018.04.13110.1016/j.chemosphere.2018.04.131 ↗
65. 10.1038/srep3796010.1038/srep37960 ↗
66. 10.1002/app.3393410.1002/app.33934 ↗
67. 10.1007/s00289-017-2049-410.1007/s00289-017-2049-4 ↗
68. 10.1080/10667857.2018.147323410.1080/10667857.2018.1473234 ↗
69. 10.1016/j.reactfunctpolym.2015.12.00910.1016/j.reactfunctpolym.2015.12.009 ↗
70. 10.1080/03091902.2019.160695010.1080/03091902.2019.1606950 ↗
71. 10.1016/j.ijpharm.2014.10.03610.1016/j.ijpharm.2014.10.036 ↗
72. Iqbal H · Int J Biol Macromol · 2019 · 1 · 921
73. 10.5604/01.3001.0014.314810.5604/01.3001.0014.3148 ↗
74. Rutala WA · Atlanta, GA: Centers for Disease Control and Prevention · 2008 · 1
75. 10.1007/s12247-019-09383-710.1007/s12247-019-09383-7 ↗
76. Duzyer S · Tekst Appl · 2013 · 23 · 319
77. 10.1177/204173141664881010.1177/2041731416648810 ↗
78. 10.1016/j.ijpharm.2017.12.00310.1016/j.ijpharm.2017.12.003 ↗
79. 10.1016/j.eurpolymj.2016.07.01610.1016/j.eurpolymj.2016.07.016 ↗